REDWOOD CITY, Calif.
Aug. 8, 2011
/PRNewswire/ -- Cardica, Inc. (Nasdaq: CRDC) today announced that
Bernard A. Hausen
, M.D., Ph.D., the company's president and chief executive officer, is scheduled to present a corporate overview and update at the Wedbush 2011 Life Sciences Management Access Conference in
New York, NY
Tuesday, August 16th
9:10 a.m. Eastern Time
To access the live and subsequently archived webcast of the presentation, go to the Investor Relations section of the company's website at
. Please connect to the website at least 15 minutes prior to the presentation to allow for any necessary software downloads.
Cardica designs and manufactures proprietary stapling and anastomotic devices for cardiac and endoscopic surgical procedures. Cardica's technology portfolio is intended to minimize operating time and enable minimally-invasive and robot-assisted surgeries. Cardica manufactures and markets its automated anastomosis systems, the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System, for coronary artery bypass graft (CABG) surgery and has shipped over 34,500 units throughout the world. In addition, the company is developing the Cardica Microcutter XPRESS™ 30, a true multi-fire endoscopic stapling device designed to be used in a variety of procedures, including bariatric, colorectal, thoracic and general surgery. The Cardica Microcutter XPRESS 30 requires a 510(k) review and is not yet commercially available in the U.S.
SOURCE Cardica, Inc.